Cell line · CVCL_0020
Papers43
1 to 20 of 43
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Hypoxia-induced circSPECC1 drives temozolomide resistance in glioblastoma via IGF2BP2-mediated PGK1 mRNA stabilization. | Cell Death Dis | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Non-Temperature-Induced Antitumor Effects of Amplitude-Modulated Radiofrequency: Molecular and Functional Synergies with Radiotherapy. | Cancers (Basel) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Cinobufotalin reduces glioblastoma resistance to temozolomide by inhibiting the CCL5-mediated PI3K/Akt/mTOR signaling pathway. | Transl Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Spirohydantoin derivatives exert dopamine D2-like receptor-independent cytotoxicity in glioblastoma cells with possible involvement of calpain inhibition. | Sci Rep | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Functional loss of ERBB receptor feedback inhibitor 1 (MIG6) promotes glioblastoma tumorigenesis by aberrant activation of epidermal growth factor receptor (EGFR). | Mol Oncol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Copper induces neuron-sparing, ferredoxin 1-independent astrocyte toxicity mediated by oxidative stress. | J Neurochem | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Oncolytic viruses engineered to enforce cholesterol efflux restore tumor-associated macrophage phagocytosis and anti-tumor immunity in glioblastoma. | Nat Commun | 2023 | Its Methods give the RRID and name the line | PubMed | |
| The Combination of Δ9-Tetrahydrocannabinol and Cannabidiol Suppresses Mitochondrial Respiration of Human Glioblastoma Cells via Downregulation of Specific Respiratory Chain Proteins. | Cancers (Basel) | 2022 | Its Methods give the RRID and name the line | PubMed | |
| A Sensitive LC-MS/MS Method for the Simultaneous Determination of Two Thia-Analogous Indirubin N-Glycosides and Indirubin-3'-Monoxime in Plasma and Cell Culture Medium. | Molecules | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Fibrin gel enhances the antitumor effects of chimeric antigen receptor T cells in glioblastoma. | Sci Adv | 2021 | Its Methods give the RRID and name the line | PubMed | |
| RNA sequencing data of different grade astrocytoma cell lines. | Data Brief | 2021 | Cellosaurus cites it | PubMed | |
| B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres. | EBioMedicine | 2019 | Its Methods give the RRID and name the line | PubMed | |
| Next-generation characterization of the Cancer Cell Line Encyclopedia. | Nature | 2019 | Cellosaurus cites it | PubMed | |
| An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines. | Cancer Res | 2019 | Cellosaurus cites it | PubMed | |
| Origin of the U87MG glioma cell line: Good news and bad news. | Sci Transl Med | 2016 | Cellosaurus cites it | PubMed | |
| DNA fingerprinting of glioma cell lines and considerations on similarity measurements. | Neuro Oncol | 2012 | Cellosaurus cites it | PubMed | |
| The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. | Nature | 2012 | Cellosaurus cites it | PubMed | |
| A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers. | Cancer Res | 2010 | Cellosaurus cites it | PubMed | |
| IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas. | Neuro Oncol | 2009 | Cellosaurus cites it | PubMed | |
| Molecular and phenotypic characterisation of paediatric glioma cell lines as models for preclinical drug development. | PLoS One | 2009 | Cellosaurus cites it | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0020/papers